These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 12442457)
1. [Prolonged (24 weeks) treatment of chronic hepatitis type B with recombinant interferon-alpha]. Matsuda H; Kashiwagi T Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):629-34. PubMed ID: 12442457 [No Abstract] [Full Text] [Related]
2. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911 [TBL] [Abstract][Full Text] [Related]
3. Platelet and white blood cell counts during therapy with different types of alpha interferon in patients with chronic viral hepatitis. Investigators of the Alpha Interferon Study Group of Piemonte, Italy. Colombatto P; Oliveri F; Leandro G; Baldi M; Capalbo M; Rocca G; Brunetto MR; Bonino F Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):441-7. PubMed ID: 9494854 [TBL] [Abstract][Full Text] [Related]
4. [Generation of neutralizing anti-interferon antibodies and factors influencing their production in chronic hepatitis B patients receiving recombinant interferon-alpha treatment]. Mao QG; Luo KX; Zhang MX; Liu D; Hou JL Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1319-22. PubMed ID: 14678902 [TBL] [Abstract][Full Text] [Related]
5. Current knowledge on treatment of chronic hepatitis B in children. Lebensztejn DM; Kaczmarski M Med Sci Monit; 2000; 6(1):198-203. PubMed ID: 11208310 [TBL] [Abstract][Full Text] [Related]
6. Retreatment with human leukocyte interferon alpha of chronic hepatitis C, recurring after a first cycle with recombinant interferon. Carrara M; Azzurro M; Adamo S Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):234-5. PubMed ID: 9675668 [No Abstract] [Full Text] [Related]
7. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up]. Liu DL; Luo KX; Feng XR; Fu QX; Hou JL Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996 [TBL] [Abstract][Full Text] [Related]
8. [Antiviral therapy with recombinant alpha-interferon in chronic B virus hepatitis]. Brahm J; Hurtado C Rev Med Chil; 1990 Jun; 118(6):667-70. PubMed ID: 1775789 [TBL] [Abstract][Full Text] [Related]
9. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response]. Fedorchenko SV; Vovk AD; Rybalko SL Ter Arkh; 1994; 66(2):24-9. PubMed ID: 8160138 [TBL] [Abstract][Full Text] [Related]
10. [Viral breakthrough and neutralizing anti-interferon antibody production in chronic hepatitis B patients treated with recombinant interferon-alpha]. Liu DL; Luo KX; Feng XR; Zhang MX; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):422-4. PubMed ID: 17594805 [TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha therapy alters glucose metabolism in patients with chronic hepatitis B. Tanaka H; Shiota G; Kawasaki H J Med; 1997; 28(5-6):325-34. PubMed ID: 9604791 [TBL] [Abstract][Full Text] [Related]
12. [Interferon in the treatment of acute viral hepatitis B]. Gorbarets IP; Ketiladze ES; Farber NA; Bugaeva NP; Nemtsova EV Ter Arkh; 1989; 61(8):69-71. PubMed ID: 2686075 [TBL] [Abstract][Full Text] [Related]
13. [A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha]. Mao QG; Liu DL; Zhang MX; Feng XR; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):24-6. PubMed ID: 15670486 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic non-A, non-B hepatitis with a combination therapy of interferon and an immunopotentiator]. Ooka T Nihon Rinsho; 1988 Dec; 46(12):2703-14. PubMed ID: 3149344 [No Abstract] [Full Text] [Related]
15. [The treatment of chronic viral hepatitis with recombinant alpha-2 interferon: meta analysis and clinical contribution]. Raffa S; Albiani B; Allegritti A; Fontana M; Loria C; Manzi P; Sottili S; Grassi M Clin Ter; 1997 Oct; 148(10):421-35. PubMed ID: 9470304 [TBL] [Abstract][Full Text] [Related]
16. [Clinical profiles of circulating dendritic cell subsets in chronically HBV-infected patients with interferon-alpha treatment]. Yan T; Wang HF; Ji W; Zhang AM; Zhang Z; Zhang H; Wang FS Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1177-81. PubMed ID: 16029591 [TBL] [Abstract][Full Text] [Related]
17. [Predictor of effect of interferon-alpha on patients with hepatitis B: Th1/Th2 type cytokines]. Xing T; Zhang L; Lu Q Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):268-70. PubMed ID: 11798769 [TBL] [Abstract][Full Text] [Related]
18. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Mazzella G; Saracco G; Festi D; Rosina F; Marchetto S; Jaboli F; Sostegni R; Pezzoli A; Azzaroli F; Cancellieri C; Montagnani M; Roda E; Rizzetto M Am J Gastroenterol; 1999 Aug; 94(8):2246-50. PubMed ID: 10445557 [TBL] [Abstract][Full Text] [Related]
19. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770 [TBL] [Abstract][Full Text] [Related]
20. IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-alpha therapy. Gregorek H; Madaliński K; Woynarowski M; Mikolajewicz J; Syczewska M; Socha J J Infect Dis; 2000 Jun; 181(6):2059-62. PubMed ID: 10837193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]